|

AUR103 Calcium Clinical Trials

1 actively recruiting trial

Also known as: Capecitabine, Trastuzumab

Pipeline

Phase 1/2: 1

Top Sponsors

  • Aurigene Discovery Technologies Limited1

Indications

  • HER 2 Positive Gastric Cancer1
  • Gastroesophageal Junction Adenocarcinoma1
  • Cancer1

Other1 trial

A Phase 1b/2 Clinical Trial Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AUR103 Calcium in Patients With HER2-positive Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.